FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

George Tidmarsh, a Stanford University physician who founded Horizon Pharma and later ran La Jolla Pharma, was named head of ...

FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...

Biotech veteran and Stanford physician-scientist brings 30 years of translational research and regulatory experience to ...

The FDA will select at most five companies that align with national priorities, including lower drug prices and increased ...

A deep dive into the implications of the Replimune CRL that surprised insiders and investors, the role of new leadership at ...

The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.

"The FDA's new Commissioner’s National Priority Voucher program is a visionary initiative that acknowledges the urgent need for innovation in areas vital to the nation’s well-being.